Internal Medicine
Effective Friday, June 10, 2022, MAHEC will no longer offer monoclonal antibody infusions. Current data shows that oral prescription medications are preferred treatment options and as of July, Bebtelivomab will no longer be supplied.
Learn MorePost-Acute COVID is an emerging syndrome that is sometimes referred to as long COVID, chronic COVID, or long-hauler syndrome. This condition involves COVID symptoms that last for more than two weeks after a diagnosis and can persist for 8 weeks or longer.
Learn More
